Auxilium Pharmaceuticals Inc (NASDAQ:AUXL)

CAPS Rating: 3 out of 5

A specialty biopharmaceutical company with a focus on developing and marketing products to urologists, endocrinologists, orthopedists and select primary care physicians.

Recs

0
Player Avatar pchop123 (79.69) Submitted: 1/29/2013 1:41:23 PM : Outperform Start Price: $17.67 AUXL Score: +5.10

positive window of opportunity here

Featured Broker Partners


Advertisement